These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21224508)

  • 1. The S140G KCNQ1 atrial fibrillation mutation affects 'I(KS)' profile during both atrial and ventricular action potentials.
    El Harchi A; Zhang H; Hancox JC
    J Physiol Pharmacol; 2010 Dec; 61(6):759-64. PubMed ID: 21224508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action potential clamp and mefloquine sensitivity of recombinant 'I KS' channels incorporating the V307L KCNQ1 mutation.
    El Harchi A; McPate MJ; Zhang YH; Zhang H; Hancox JC
    J Physiol Pharmacol; 2010 Apr; 61(2):123-31. PubMed ID: 20436212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective targeting of gain-of-function KCNQ1 mutations predisposing to atrial fibrillation.
    Campbell CM; Campbell JD; Thompson CH; Galimberti ES; Darbar D; Vanoye CG; George AL
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):960-6. PubMed ID: 24006450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel KCNQ1 missense mutation identified in a patient with juvenile-onset atrial fibrillation causes constitutively open IKs channels.
    Hasegawa K; Ohno S; Ashihara T; Itoh H; Ding WG; Toyoda F; Makiyama T; Aoki H; Nakamura Y; Delisle BP; Matsuura H; Horie M
    Heart Rhythm; 2014 Jan; 11(1):67-75. PubMed ID: 24096004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico investigation of a KCNQ1 mutation associated with familial atrial fibrillation.
    Hancox JC; Kharche S; El Harchi A; Stott J; Law P; Zhang H
    J Electrocardiol; 2014; 47(2):158-65. PubMed ID: 24411289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrillation in KCNE1-null mice.
    Temple J; Frias P; Rottman J; Yang T; Wu Y; Verheijck EE; Zhang W; Siprachanh C; Kanki H; Atkinson JB; King P; Anderson ME; Kupershmidt S; Roden DM
    Circ Res; 2005 Jul; 97(1):62-9. PubMed ID: 15947250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-arrhythmogenic effects of the S140G KCNQ1 mutation in human atrial fibrillation - insights from modelling.
    Kharche S; Adeniran I; Stott J; Law P; Boyett MR; Hancox JC; Zhang H
    J Physiol; 2012 Sep; 590(18):4501-14. PubMed ID: 22508963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KCNQ1 gain-of-function mutation in familial atrial fibrillation.
    Chen YH; Xu SJ; Bendahhou S; Wang XL; Wang Y; Xu WY; Jin HW; Sun H; Su XY; Zhuang QN; Yang YQ; Li YB; Liu Y; Xu HJ; Li XF; Ma N; Mou CP; Chen Z; Barhanin J; Huang W
    Science; 2003 Jan; 299(5604):251-4. PubMed ID: 12522251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calmodulin is essential for cardiac IKS channel gating and assembly: impaired function in long-QT mutations.
    Shamgar L; Ma L; Schmitt N; Haitin Y; Peretz A; Wiener R; Hirsch J; Pongs O; Attali B
    Circ Res; 2006 Apr; 98(8):1055-63. PubMed ID: 16556865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms by which atrial fibrillation-associated mutations in the S1 domain of KCNQ1 slow deactivation of IKs channels.
    Restier L; Cheng L; Sanguinetti MC
    J Physiol; 2008 Sep; 586(17):4179-91. PubMed ID: 18599533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of the short QT N588K mutation at 37 degrees C on hERG K+ channel current during ventricular, Purkinje fibre and atrial action potentials: an action potential clamp study.
    McPate MJ; Zhang H; Adeniran I; Cordeiro JM; Witchel HJ; Hancox JC
    J Physiol Pharmacol; 2009 Mar; 60(1):23-41. PubMed ID: 19439805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of KCNQ1 current by atrial fibrillation-associated KCNE4 (145E/D) gene polymorphism.
    Ma KJ; Li N; Teng SY; Zhang YH; Sun Q; Gu DF; Pu JL
    Chin Med J (Engl); 2007 Jan; 120(2):150-4. PubMed ID: 17335661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gating mechanisms underlying deactivation slowing by two KCNQ1 atrial fibrillation mutations.
    Peng G; Barro-Soria R; Sampson KJ; Larsson HP; Kass RS
    Sci Rep; 2017 Apr; 7():45911. PubMed ID: 28383569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biophysical characteristics of a new mutation on the KCNQ1 potassium channel (L251P) causing long QT syndrome.
    Deschênes D; Acharfi S; Pouliot V; Hegele R; Krahn A; Daleau P; Chahine M
    Can J Physiol Pharmacol; 2003 Feb; 81(2):129-34. PubMed ID: 12710526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of KCNQ1 atrial fibrillation mutations reveals distinct dependence on KCNE1.
    Chan PJ; Osteen JD; Xiong D; Bohnen MS; Doshi D; Sampson KJ; Marx SO; Karlin A; Kass RS
    J Gen Physiol; 2012 Feb; 139(2):135-44. PubMed ID: 22250012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation?
    Otway R; Vandenberg JI; Guo G; Varghese A; Castro ML; Liu J; Zhao J; Bursill JA; Wyse KR; Crotty H; Baddeley O; Walker B; Kuchar D; Thorburn C; Fatkin D
    J Am Coll Cardiol; 2007 Feb; 49(5):578-86. PubMed ID: 17276182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional effects of a KCNQ1 mutation associated with the long QT syndrome.
    Boulet IR; Raes AL; Ottschytsch N; Snyders DJ
    Cardiovasc Res; 2006 Jun; 70(3):466-74. PubMed ID: 16564513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant-negative control of cAMP-dependent IKs upregulation in human long-QT syndrome type 1.
    Heijman J; Spätjens RL; Seyen SR; Lentink V; Kuijpers HJ; Boulet IR; de Windt LJ; David M; Volders PG
    Circ Res; 2012 Jan; 110(2):211-9. PubMed ID: 22095730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of HERG current profile during the cardiac ventricular action potential, following a pore mutation.
    Hancox JC; Witchel HJ; Varghese A
    Biochem Biophys Res Commun; 1998 Dec; 253(3):719-24. PubMed ID: 9918793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide inhibits Kv4.3 and human cardiac transient outward potassium current (Ito1).
    Gómez R; Núñez L; Vaquero M; Amorós I; Barana A; de Prada T; Macaya C; Maroto L; Rodríguez E; Caballero R; López-Farré A; Tamargo J; Delpón E
    Cardiovasc Res; 2008 Dec; 80(3):375-84. PubMed ID: 18678642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.